| Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies S Jain, JA Coulter, AR Hounsell, KT Butterworth, SJ McMahon, ... International Journal of Radiation Oncology* Biology* Physics 79 (2), 531-539, 2011 | 549 | 2011 |
| Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles SJ McMahon, WB Hyland, MF Muir, JA Coulter, S Jain, KT Butterworth, ... Scientific reports 1 (1), 18, 2011 | 459 | 2011 |
| Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy KT Butterworth, JA Coulter, S Jain, J Forker, SJ McMahon, G Schettino, ... Nanotechnology 21 (29), 295101, 2010 | 299 | 2010 |
| Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy SJ McMahon, WB Hyland, MF Muir, JA Coulter, S Jain, KT Butterworth, ... Radiotherapy and Oncology 100 (3), 412-416, 2011 | 239 | 2011 |
| Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles JA Coulter, S Jain, KT Butterworth, LE Taggart, GR Dickson, SJ McMahon, ... International journal of nanomedicine, 2673-2685, 2012 | 215 | 2012 |
| Imaging and radiation effects of gold nanoparticles in tumour cells HN McQuaid, MF Muir, LE Taggart, SJ McMahon, JA Coulter, WB Hyland, ... Scientific reports 6 (1), 19442, 2016 | 146 | 2016 |
| Nitric oxide—a novel therapeutic for cancer JA Coulter, HO McCarthy, J Xiang, W Roedl, E Wagner, T Robson, ... Nitric oxide 19 (2), 192-198, 2008 | 137 | 2008 |
| Gold nanoparticle surface functionalization: A necessary requirement in the development of novel nanotherapeutics JR Nicol, D Dixon, JA Coulter Nanomedicine 10 (8), 1315-1326, 2015 | 126 | 2015 |
| CD44 increases the efficiency of distant metastasis of breast cancer S McFarlane, JA Coulter, P Tibbits, A O'Grady, C McFarlane, ... Oncotarget 6 (13), 11465, 2015 | 117 | 2015 |
| Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions S Jain, JA Coulter, KT Butterworth, AR Hounsell, SJ McMahon, ... Radiotherapy and Oncology 110 (2), 342-347, 2014 | 109 | 2014 |
| Radiosensitising nanoparticles as novel cancer therapeutics—pipe dream or realistic prospect? JA Coulter, WB Hyland, J Nicol, FJ Currell Clinical Oncology 25 (10), 593-603, 2013 | 101 | 2013 |
| Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma PJ Maxwell, J Coulter, SM Walker, M McKechnie, J Neisen, N McCabe, ... European urology 64 (2), 177-188, 2013 | 95 | 2013 |
| Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells C Adams, HO McCarthy, JA Coulter, J Worthington, C Murphy, T Robson, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2009 | 80 | 2009 |
| Energy dependence of gold nanoparticle radiosensitization in plasmid DNA SJ McMahon, WB Hyland, E Brun, KT Butterworth, JA Coulter, T Douki, ... The Journal of Physical Chemistry C 115 (41), 20160-20167, 2011 | 79 | 2011 |
| DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen G Cole, AA Ali, E McErlean, EJ Mulholland, A Short, CM McCrudden, ... Acta Biomaterialia 96, 480-490, 2019 | 74 | 2019 |
| Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy KT Butterworth, JR Nicol, M Ghita, S Rosa, P Chaudhary, CK McGarry, ... Nanomedicine 11 (16), 2035-2047, 2016 | 62 | 2016 |
| Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device J McCaffrey, CM McCrudden, AA Ali, AS Massey, JW McBride, ... Journal of controlled release 226, 238-247, 2016 | 57 | 2016 |
| Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride AJ Paredes, F Volpe-Zanutto, AD Permana, AJ Murphy, CJ Picco, LK Vora, ... International journal of pharmaceutics 606, 120885, 2021 | 49 | 2021 |
| Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions HO McCarthy, JA Coulter, T Robson, DG Hirst Journal of Pharmacy and Pharmacology 60 (8), 999-1017, 2008 | 48 | 2008 |
| Erythropoietin drives breast cancer progression by activation of its receptor EPOR KK Chan, KB Matchett, JA Coulter, HF Yuen, CM McCrudden, SD Zhang, ... Oncotarget 8 (24), 38251, 2017 | 44 | 2017 |
